91蜜桃视频

产物资料

骨硬化病相关跨膜蛋白1抗体

如果您对该产物感兴趣的话,可以
产物名称: 骨硬化病相关跨膜蛋白1抗体
产物型号: OSTM1
产物展商: 单克隆抗体/多克隆抗体
产物文档: 无相关文档

简单介绍

骨硬化病相关跨膜蛋白1抗体应用于IHC、WB、 IF、IP、ELISA等科研实验,按理化性质和生物学功能IgM、IgG、IgA、IgE、IgD五类。按抗体的来源,可将其分为天然抗体和**抗体。骨硬化病相关跨膜蛋白1抗体生产每个流程都执行严格的检测标准,保证蛋白抗原产物质量,质量稳定,实验效果明显。


骨硬化病相关跨膜蛋白1抗体  的详细介绍

骨硬化病相关跨膜蛋白1抗体

规格:1尘驳/1尘濒

英文名: OSTM1

别名: GAIP-interacting protein N terminus; GIPN; GL antibody Grey lethal osteopetrosis; HSPC019; OPTB5; Osteopetrosis-associated transmembrane protein 1; Ostm1; OSTM1_HUMAN.

分子量: 33kDa

储存液:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glyce

克隆类型:笔辞濒测肠濒辞苍补濒

亚型:滨驳骋

纯化方法:affinity purified by Protein A

**原:KLH conjugated synthetic peptide derived from human OSTM1

交叉反应:Human, Mouse, Rat, Pig,

细胞定位:细胞膜

骨硬化病相关跨膜蛋白1抗体产物介绍:background: OSTM1 (osteopetrosis associated transmembrane protein 1), also known as gl (gray-lethal) or HSPC019, is a 338 amino acid single-pass type I membrane protein that is expressed primarily in osteoclasts and melanocytes as well as brain, kidney and spleen. Bone autosomal recessive osteopetrosis (ARO) is the most severe form of hereditary bone disease whose cellular basis is in the osteoclast and is characterized by abnormally dense bone, due to defective resorption of immature bone. ARO is suggested to be caused by mutations in the OSTM1 gene. The disorder occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or hood. Defects in the OSTM1 gene are also the cause of the spontaneous gl mutant, which is responsible for a coat color defect in mice. Function: Required for osteoclast and melanocyte maturation and function (By similarity). Subcellular Location: Membrane; Single-pass type I membrane protein. DISEASE: Defects in OSTM1 are the cause of osteopetrosis骨硬化病相关跨膜蛋白1抗体 autosomal recessive type 5 (OPTB5) [MIM:259720]; also called infantile malignant osteopetrosis 3. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. The disorder occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or hood. OPTB5 patients manifest primary central nervous system involvement in addition to the classical stigmata of severe bone sclerosis,骨硬化病相关跨膜蛋白1抗体 growth failure, anemia, thrombocytopenia and visual impairment with optic atrophy. Database links:   UniProtKB/Swiss-Prot: Q86WC4.1 Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

骨硬化病相关跨膜蛋白1抗体产物应用:WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-300 IF=1:50-200 (石蜡切片需做抗原修复) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.

研究领域:

储存条件: Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

来源: Rabbit

外观: Lyophilized or Liquid


产物留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键础濒迟+厂或颁迟谤濒+贰苍迟别谤发送信息!
2.如有必要,请您留下您的详细联系方式!